Add BrightSurf on Google Email

AI-driven framework enables precise prediction of RNA splicing and isoform usage

Researchers develop an AI framework to accurately predict RNA splicing and isoform usage, addressing the need for better management strategies in patients with Hutchinson-Gilford Progeria Syndrome. The study highlights the importance of multidisciplinary coordination and prompt decision-making in this high-risk population.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeCase study·DateMay 19, 2026

Gut problems in people with a genetic disorder are not cause by structural problems with the gullet, as previously assumed

Research reveals that persistent upper gut symptoms experienced by people with hEDS are due to heightened sensitivity and altered signalling between the gut and brain, rather than structural abnormalities. The findings highlight the need for a comprehensive biopsychosocial approach to care.

SourceUniversity of Nottingham·JournalClinical Gastroenterology and Hepatology·TypeRandomized controlled/clinical trial·DateMay 12, 2026

Molecular basis of multicentric carpotarsal osteolysis (MCTO) nephropathy: Pathogenic MAFB accumulation and PI3K/AKT signaling

Researchers discovered a molecular link between multicentric carpotarsal osteolysis (MCTO) and kidney disease, highlighting pathogenic MAFB accumulation and PI3K/AKT signaling. Treatment with imatinib suppressed AKT phosphorylation and attenuated glomerular injury in mice.

SourceUniversity of Tsukuba·JournalJournal of the American Society of Nephrology·DateMay 11, 2026

New AI tool developed by Stowers Institute and Helmholtz Munich scientists predicts how cells choose their future — helping uncover hidden drivers of development

Researchers developed RegVelo, an AI framework that models cellular dynamics and gene regulation to predict cellular fate decisions. The model traces developmental trajectories and simulates regulatory interactions, providing insights into hidden drivers of development and potential therapeutic targets.

Children with rare, debilitating brain diseases suffer from mutations in a little-known protein complex

Researchers have mapped the structure and mechanics of a critical cellular machine that malfunctions in people with rare genetic disorders. The discovery could lead to new treatments and faster diagnoses for children with conditions like infantile encephalopathy, corpus callosum hypoplasia, and Kenny-Caffey syndrome.

SourceUniversity of California - Davis·JournalScience Advances·TypeExperimental study·DateMay 8, 2026

Cold hands, warm heart — Body temperature a key factor in where TRPM4 mutations cause disease

Researchers discovered that body temperature plays a key role in which tissues are affected by TRPM4 ion channel mutations. The findings explain why disease-causing TRPM4 mutations lead to mutually exclusive conditions, such as severe skin diseases like PSEK and heart disorders like progressive familial heart block.

SourceUniversity of California - Davis Health·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMay 1, 2026

How do astrocytes contribute to fragile X syndrome?

Researchers from the Salk Institute found that astrocytes play a crucial role in fragile X syndrome symptoms. Correcting dysregulations in star-shaped brain cells improved some symptoms, including reduced seizures and restored molecular balances in a mouse model of FXS. The study validates the importance of studying astrocytes in FXS r...

SourceSalk Institute·JournalNature Communications·DateApr 23, 2026

Cystic fibrosis: research advances

A study coordinated by the University of Trento has identified a gene therapy for individuals with cystic fibrosis caused by a specific mutation, offering new hope for those currently dependent on drugs. The therapy uses advanced gene editing technology to correct the DNA mutation responsible for the disease.

SourceUniversità di Trento·JournalScience Translational Medicine·TypeExperimental study·DateApr 23, 2026

Hearing restoration from gene therapy for inherited deafness lasts years, new trial results show

A new international study shows that gene therapy targeting the OTOF gene successfully restored hearing in most participants, with significant improvements in speech perception and language skills. The treatment remained safe and effective for up to 2.5 years, offering new hope for individuals with inherited deafness.

SourceMass Eye and Ear·JournalNature·TypeRandomized controlled/clinical trial·DateApr 22, 2026

Fondazione Telethon’S Genomic Program end the diagnostic odissey for hundreds of children

The program achieved a definitive genetic diagnosis in nearly half of enrolled children, identifying pathogenic variants across 330 genes. Families received timely diagnoses, allowing accurate genetic counseling and informed reproductive choices, while guiding clinical management and opening access to targeted therapies.

SourceFondazione Telethon·JournalGenetics in Medicine Open·TypeExperimental study·DateApr 20, 2026

CURE SYNGAP1 announces 2026 board of trustees transition

The organization welcomes Craig Bower, Allison Hirsch Hadar, Susan Johnson, Andrew Schillaci, and Ed Warshauer to its Board of Trustees, succeeding outgoing members. These new leaders join a mission primed for global impact, signaling a reinforced commitment to accelerating safe, effective, and targeted therapies.

Researchers identify new genetic disease that interferes with brain development

Scientists have discovered a new rare genetic disease caused by a mutation in the RPN1 gene, which affects glycosylation and leads to protein instability. The disease, now termed RPN1-CDG, is characterized by neurodevelopmental issues and has expanded the number of genes associated with OST complex diseases.

SourceSanford Burnham Prebys·JournalHuman Genetics and Genomics Advances·TypeExperimental study·DateApr 13, 2026

Researchers identify blood-based biomarker for cancer risk in people with Lynch Syndrome

A new blood-based biomarker has been discovered to help identify individuals at higher risk of developing cancer in people with Lynch Syndrome. The biomarker uses immune signatures detected in blood samples to provide unique characteristics that can detect cancer risk, allowing for early detection and personalized surveillance.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNature Communications·DateApr 6, 2026

Answering an urgent need

The Linda and Mike Mussallem Foundation has donated to USC's Keck School of Medicine to enhance clinical trials for individuals with Down syndrome at risk for Alzheimer's. This will increase domestic and international sites, accelerating the development of treatments specifically for this population.

Medical centers highlight responsible ways to share genetic disease risk information

A study by Cincinnati Children's Hospital Medical Center and the eMERGE network found that sharing genetic disease risk information with patients can be done responsibly, with a 70% success rate. The team shared results with over 24,000 people using various methods, including one-to-one conversations for those with higher-risk findings.

SourceCincinnati Children's Hospital Medical Center·JournalAmerican Journal of Human Genetics·TypeData/statistical analysis·DateMar 23, 2026

Mitochondria identified as key player in a rare disease causing microcephaly

A study led by Dr. Marco Milán identified mitochondria as a key player in a rare disease causing microcephaly, a condition where the brain develops to a smaller size. The researchers found that mitochondria dysfunction leads to proteotoxic stress, causing cells to accumulate errors in chromosome distribution, resulting in microcephaly.

Location, location, location: For potassium channels, it depends on functionality

Potassium KCNQ2/3 channels need full functionality to work properly in the brain and reach their correct location. This is linked to their regulation by protein ankG. Altering channel functionality affects neuronal excitability and may contribute to developing new therapeutic strategies for epilepsy.

SourceThe University of Osaka·JournalProceedings of the National Academy of Sciences·TypeImaging analysis·DateMar 3, 2026

Here we grow: chondrocytes’ behavior reveals novel targets for bone growth disorders

A team at The University of Osaka has identified a signaling molecule called FGFR3 and a pathway called CREB as key in regulating bone growth. Cells carrying the genetic mutation associated with achondroplasia accumulate in the resting zone and show abnormal behaviors, which included abnormal patterns of division and migration.

SourceThe University of Osaka·JournalNature Communications·TypeExperimental study·DateFeb 26, 2026

Two wrongs make a right: how two damaging variants can restore health

A study published in PNAS found that over 60% of pairs of damaging genetic variants can restore enzyme activity when combined, challenging long-held assumptions about genetics. This phenomenon, known as intragenic complementation, has implications for rare disease diagnosis and treatment.

SourcePacific Northwest Research Institute·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 12, 2026

Genes aren’t destiny for inherited blindness, study shows

A new study by Mass General Brigham researchers found that genetic variants thought to always cause inherited blindness occur in only 28% of people who carry them. The findings challenge traditional models of rare disease genetics, suggesting a need for updated understanding and potentially impacting the development of new treatments.

SourceMass General Brigham·JournalAmerican Journal of Human Genetics·TypeData/statistical analysis·DateDec 22, 2025

Changing the paradigm on hypermobile Ehlers-Danlos Syndrome: Connective tissues don’t tell the whole story

A recent study from Medical University of South Carolina research team challenges the notion that hypermobile Ehlers-Danlos Syndrome is an isolated connective tissue disorder. The studies reveal a genetic variant associated with the disease and disruption of the immune system, which may be the underlying cause. This new understanding a...

SourceMedical University of South Carolina·JournalImmunoHorizons·TypeExperimental study·DateDec 16, 2025